June 10, 2025

Cancer Pain Study Shows Promise for Novel Neurotoxin

A Phase I study of intrathecal resiniferatoxin in patients with advanced cancer pain shows promising reductions in pain and opioid use, with durable effects and manageable side effects.

Conexiant

June 09, 2025

Appendix Tumors Climb for Millennials, Gen Z

Younger generations—particularly individuals born after 1980—face higher rates of appendiceal cancer, with incidence increasing more than fourfold in recent decades, according to a new study.

Conexiant

June 09, 2025

Steroid Use Quietly Weakens Skin's Elasticity: Study

Long-term steroid use can damage skin by silently disrupting elastic fibers before visible thinning appears, new research shows.

Conexiant

June 03, 2025

FDA Grants Breakthrough Status to Shield Test

The methylation-based blood assay is designed for screening multiple cancer types.

Conexiant

June 02, 2025

Restrictive Platelet Thresholds Endorsed in New Guidelines

International experts reviewed decades of data and endorsed lower platelet transfusion thresholds.

Conexiant

May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant

May 27, 2025

Mucous Membrane Pemphigoid Linked to Higher Skin Cancer Risk

Investigators found that patients with mucous membrane pemphigoid, especially those with severe disease, face increased risks of squamous and basal cell carcinomas.

Conexiant

May 23, 2025

New Inhaled Treprostinil Option Approved

Yutrepia represents an additional therapeutic option within the prostacyclin class for the management of PAH and PH-ILD.

Conexiant

May 23, 2025

Longer Fixation Reduces Artifacts in Testicular Tumors

Longer formalin fixation reduced tumor displacement artifacts in testicular germ cell tumors, helping pathologists distinguish true from pseudo–lymphovascular invasion, especially in larger seminomas.

Conexiant